Condition

Metastatic Breast Cancer With a Isolated Brain Progression (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

UNICANCER (1)

Collaborator

ARCAGY/ GINECO GROUP (1)

Seagen Inc. (1)

Intervention

hormone therapy (1)

pertuzumab (1)

pertuzumab/ trastuzumab (1)

trastuzumab (1)

tucatinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

metastatic breast cancer with a isolated brain progression

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Breast Cancer With a Isolated Brain Progression Trial in France (Tucatinib, Pertuzumab, Trastuzumab)

Recruiting

Metastatic Breast Cancer With a Isolated Brain Progression

Tucatinib
+4 more

Angers, France
+33 more

Aug 10, 2022